https://www.limsforum.com The Global Laboratory, Informatics, Medical and Science Professional Community Wed, 16 Sep 2026 20:04:06 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.13 https://s3.limsforum.com/www.limsforum.com/wp-content/uploads/cropped-LIMSforum-Fav-32x32.png https://www.limsforum.com 32 32 https://www.limsforum.com/how-ai-is-cutting-protocol-amendments-and-accelerating-clinical-trials/116493/?utm_source=rss&utm_medium=rss&utm_campaign=how-ai-is-cutting-protocol-amendments-and-accelerating-clinical-trials https://www.limsforum.com/how-ai-is-cutting-protocol-amendments-and-accelerating-clinical-trials/116493/#respond Wed, 16 Sep 2026 20:04:06 +0000 https://www.limsforum.com/how-ai-is-cutting-protocol-amendments-and-accelerating-clinical-trials/116493/ Protocol amendments add costly delays to drug development, yet roughly 23% are considered preventable. AI helps sponsors catch design flaws, assess feasibility, and simulate operational performance before enrollment begins, reducing costly mid-trial changes while improving protocol quality and shortening development cycles.[Read More]]]> https://www.limsforum.com/how-ai-is-cutting-protocol-amendments-and-accelerating-clinical-trials/116493/feed/ 0 https://www.limsforum.com/accelerating-validation-in-biopharma-how-ai-transforms-eln-compliance-and-pq-execution/116482/?utm_source=rss&utm_medium=rss&utm_campaign=accelerating-validation-in-biopharma-how-ai-transforms-eln-compliance-and-pq-execution https://www.limsforum.com/accelerating-validation-in-biopharma-how-ai-transforms-eln-compliance-and-pq-execution/116482/#respond Wed, 09 Sep 2026 19:35:51 +0000 https://www.limsforum.com/accelerating-validation-in-biopharma-how-ai-transforms-eln-compliance-and-pq-execution/116482/ AI is transforming Computer System Validation in biopharmaceutical R&D by accelerating documentation and reducing repetitive work. But automation alone cannot ensure compliance. This guide explores how organizations can use AI to streamline validation while preserving human oversight, data integrity, reproducibility, and scalability.[Read More]]]> https://www.limsforum.com/accelerating-validation-in-biopharma-how-ai-transforms-eln-compliance-and-pq-execution/116482/feed/ 0 https://www.limsforum.com/navigating-pipeline-volatility-building-a-flexible-workforce-strategy-in-biopharma/116457/?utm_source=rss&utm_medium=rss&utm_campaign=navigating-pipeline-volatility-building-a-flexible-workforce-strategy-in-biopharma https://www.limsforum.com/navigating-pipeline-volatility-building-a-flexible-workforce-strategy-in-biopharma/116457/#respond Wed, 02 Sep 2026 19:31:35 +0000 https://www.limsforum.com/navigating-pipeline-volatility-building-a-flexible-workforce-strategy-in-biopharma/116457/ Biopharma pipelines can shift rapidly, creating sudden demand for specialized expertise and capacity. When programs slow, organizations must redirect resources while permanent staff may not have the skills needed elsewhere. Flexible access to specialized talent helps bridge these gaps and keep programs moving.[Read More]]]> https://www.limsforum.com/navigating-pipeline-volatility-building-a-flexible-workforce-strategy-in-biopharma/116457/feed/ 0 https://www.limsforum.com/key-takeaways-from-phuse-building-and-validating-a-trustworthy-rwd-analytics-platform/116437/?utm_source=rss&utm_medium=rss&utm_campaign=key-takeaways-from-phuse-building-and-validating-a-trustworthy-rwd-analytics-platform https://www.limsforum.com/key-takeaways-from-phuse-building-and-validating-a-trustworthy-rwd-analytics-platform/116437/#respond Thu, 27 Aug 2026 15:49:49 +0000 https://www.limsforum.com/key-takeaways-from-phuse-building-and-validating-a-trustworthy-rwd-analytics-platform/116437/ Our team attended the July 29, 2026 PHUSE webinar, “Building a Trustworthy RWD Analytic Platform,” presented by SAS. The session highlighted modern RWD/RWE architecture considerations. Below is our perspective on the webinar’s key themes and how Kalleid supports validation of RWD analytics environments, with a focus on reproducible, compliant, transparent, and audit-ready outputs.[Read More]]]> https://www.limsforum.com/key-takeaways-from-phuse-building-and-validating-a-trustworthy-rwd-analytics-platform/116437/feed/ 0 https://www.limsforum.com/data-science-and-cybersecurity-in-the-modern-lab-protecting-rd-pipelines-in-a-digitized-era/116435/?utm_source=rss&utm_medium=rss&utm_campaign=data-science-and-cybersecurity-in-the-modern-lab-protecting-rd-pipelines-in-a-digitized-era https://www.limsforum.com/data-science-and-cybersecurity-in-the-modern-lab-protecting-rd-pipelines-in-a-digitized-era/116435/#respond Thu, 27 Aug 2026 15:42:45 +0000 https://www.limsforum.com/data-science-and-cybersecurity-in-the-modern-lab-protecting-rd-pipelines-in-a-digitized-era/116435/ Modern drug discovery relies on vast amounts of proprietary data, making R&D environments prime targets for cyber threats. Protecting genomics, screening, clinical, and AI-driven systems requires more than traditional defenses. Domain-aware cybersecurity is essential for safeguarding IP, data integrity, and research continuity.[Read More]]]> https://www.limsforum.com/data-science-and-cybersecurity-in-the-modern-lab-protecting-rd-pipelines-in-a-digitized-era/116435/feed/ 0 https://www.limsforum.com/sourcing-the-right-analytics-talent-for-modern-drug-discovery-data-science-bioinformatics-or-cheminformatics/116414/?utm_source=rss&utm_medium=rss&utm_campaign=sourcing-the-right-analytics-talent-for-modern-drug-discovery-data-science-bioinformatics-or-cheminformatics https://www.limsforum.com/sourcing-the-right-analytics-talent-for-modern-drug-discovery-data-science-bioinformatics-or-cheminformatics/116414/#respond Fri, 21 Aug 2026 17:12:51 +0000 https://www.limsforum.com/sourcing-the-right-analytics-talent-for-modern-drug-discovery-data-science-bioinformatics-or-cheminformatics/116414/ Drug discovery has evolved from an empirical, wet-lab discipline into a data-driven enterprise powered by AI, genomics, CRISPR, and multi-omics. As life sciences harness massive datasets to accelerate discovery, a key challenge remains: finding analytics talent with the specialized expertise needed to turn data into breakthroughs.[Read More]]]> https://www.limsforum.com/sourcing-the-right-analytics-talent-for-modern-drug-discovery-data-science-bioinformatics-or-cheminformatics/116414/feed/ 0 https://www.limsforum.com/from-code-to-cure-accelerating-drug-discovery-for-a-global-biopharma-company-with-expert-ai-agent-developers/116406/?utm_source=rss&utm_medium=rss&utm_campaign=from-code-to-cure-accelerating-drug-discovery-for-a-global-biopharma-company-with-expert-ai-agent-developers https://www.limsforum.com/from-code-to-cure-accelerating-drug-discovery-for-a-global-biopharma-company-with-expert-ai-agent-developers/116406/#respond Mon, 17 Aug 2026 13:54:54 +0000 https://www.limsforum.com/from-code-to-cure-accelerating-drug-discovery-for-a-global-biopharma-company-with-expert-ai-agent-developers/116406/ Kalleid's case study shows how 3 embedded engineers helped a global biopharma tackle data fragmentation and slow target evaluation by building an agentic AI platform. Results included Okta authentication, expanded discovery criteria, multi-specific visualization tools, and an LLM testing framework.[Read More]]]> https://www.limsforum.com/from-code-to-cure-accelerating-drug-discovery-for-a-global-biopharma-company-with-expert-ai-agent-developers/116406/feed/ 0 https://www.limsforum.com/enhanced-project-benefit-capture-at-a-collaborative-life-sciences-non-profit/116389/?utm_source=rss&utm_medium=rss&utm_campaign=enhanced-project-benefit-capture-at-a-collaborative-life-sciences-non-profit https://www.limsforum.com/enhanced-project-benefit-capture-at-a-collaborative-life-sciences-non-profit/116389/#respond Fri, 07 Aug 2026 19:59:12 +0000 https://www.limsforum.com/enhanced-project-benefit-capture-at-a-collaborative-life-sciences-non-profit/116389/ Kalleid partnered with the Pistoia Alliance to design a standardized framework for capturing and communicating project value. The three-phase engagement delivered a Benefit Capture Template, marketing-ready pitch deck, and streamlined process flow, improving funding predictability, steering committee transparency, and visibility into project outcomes.[Read More]]]> https://www.limsforum.com/enhanced-project-benefit-capture-at-a-collaborative-life-sciences-non-profit/116389/feed/ 0 https://www.limsforum.com/116329-2/116329/?utm_source=rss&utm_medium=rss&utm_campaign=116329-2 Mon, 03 Aug 2026 14:54:30 +0000 https:/?p=116329 Generalist tech recruiters scan for Python and SQL, then send candidates who have never set foot in a regulated lab. Kalleid breaks down how that language gap stalls LIMS, CDS, and MES projects, burns out hiring managers, and misses the passive specialists entirely. The fix is a recruiter fluent in GxP, CSV, and the science behind the role.[Read More]]]> https://www.limsforum.com/116295-2/116295/?utm_source=rss&utm_medium=rss&utm_campaign=116295-2 Fri, 24 Jul 2026 17:24:27 +0000 https:/?p=116295 Artificial intelligence is transforming pharmaceutical R&D, yet fragmented, inconsistently annotated data across legacy systems limits what AI can reliably deliver. Kalleid casts ontologies as the semantic backbone linking human expertise to machine reasoning, turning scattered knowledge into AI-ready structures that accelerate trustworthy drug discovery.[Read More]]]> https://www.limsforum.com/116249-2/116249/?utm_source=rss&utm_medium=rss&utm_campaign=116249-2 Fri, 10 Jul 2026 17:45:14 +0000 https:/?p=116249 Kalleid, a laboratory IT consulting firm serving science since 2014, is now a Premier Sponsor of PHUSE, a leading global forum for data scientists. It is joining the PHUSE Nonclinical Topics Working Group to help shape non-clinical data standards, bridge regulatory requirements, and drive efficiencies from early research through clinical development.[Read More]]]> https://www.limsforum.com/116220-2/116220/?utm_source=rss&utm_medium=rss&utm_campaign=116220-2 Mon, 06 Jul 2026 13:28:32 +0000 https:/?p=116220 Biopharma labs generate mountains of data, but AI insights often stall before reaching the bench. This piece explores how agentic AI orchestration connects dry lab reasoning to physical wet lab execution, automating workflows and closing the loop between data, decisions, and experiments across the R&D lab of the future.[Read More]]]> https://www.limsforum.com/116198-2/116198/?utm_source=rss&utm_medium=rss&utm_campaign=116198-2 Mon, 29 Jun 2026 14:55:26 +0000 https:/?p=116198 Validating laboratory informatics, cloud systems, and manufacturing technology in life sciences is never just an IT project, it must follow strict GxP rules. This piece explains why generalist, keyword-driven staffing misses the mark, and how domain-aware staffing brings the regulatory fluency and audit-ready documentation that streamlines compliance.[Read More]]]> https://www.limsforum.com/116139-2/116139/?utm_source=rss&utm_medium=rss&utm_campaign=116139-2 Fri, 12 Jun 2026 17:17:17 +0000 https:/?p=116139 The Pistoia Alliance Conference 2026 united R&D IT leaders around an urgent message: drug discovery challenges can only be solved through collaboration. Kalleid recaps the stakes (83% of life sciences executives say they will miss growth targets without transformation), the rise of knowledge graphs and ontologies, and why change management remains the true bottleneck.[Read More]]]> https://www.limsforum.com/116106-2/116106/?utm_source=rss&utm_medium=rss&utm_campaign=116106-2 Thu, 04 Jun 2026 23:00:27 +0000 https:/?p=116106 A global clinical trial solutions partner managing 80+ lab partners with a fractured legacy ecosystem brought in Kalleid to validate a new Sapio LIMS. Eight months in, with the project at risk, the company gave Kalleid full implementation leadership to orchestrate workstreams, migrate 364 studies, and deliver an integrated platform.[Read More]]]> https://www.limsforum.com/116071-2/116071/?utm_source=rss&utm_medium=rss&utm_campaign=116071-2 Fri, 29 May 2026 16:36:11 +0000 https:/?p=116071 A global biopharmaceutical company built an internal application to centralize lab asset tracking and streamline equipment purchase approvals. Kalleid led the change management, training, and UAT testing workstreams to drive rapid user adoption across global R&D sites and keep the application stable through every release.[Read More]]]> https://www.limsforum.com/116024-2/116024/?utm_source=rss&utm_medium=rss&utm_campaign=116024-2 Fri, 15 May 2026 04:08:28 +0000 https:/?p=116024 Biopharma is spending big on R&D informatics, but cutting-edge platforms alone do not guarantee results. Misaligned requirements still drive rework, scope creep, and stalled rollouts. A specialized Business Analyst bridges scientists and developers, turning workflow reality into actionable specs and protecting your software investment.[Read More]]]> https://www.limsforum.com/115986-2/115986/?utm_source=rss&utm_medium=rss&utm_campaign=115986-2 Fri, 08 May 2026 04:07:55 +0000 https:/?p=115986 Kalleid examines how integrating ontologies with ELNs can bridge the gap between fragmented scientific data and actionable insights. As life sciences organizations push further into digital transformation, ontology provides the semantic framework needed to make research data findable, accessible, interoperable, and reusable across systems and teams.[Read More]]]> https://www.limsforum.com/115957-2/115957/?utm_source=rss&utm_medium=rss&utm_campaign=115957-2 https://www.limsforum.com/115957-2/115957/#respond Fri, 01 May 2026 04:08:15 +0000 https://www.limsforum.com/?p=115957 A global biopharma's R&D ecosystem was buckling under post-acquisition integration failures, legacy gaps, and SaaS migration risks that vendor support and internal IT could not resolve. This Kalleid case study shows how an embedded informatics consultant blending biology, chemistry, and software engineering restored data integrity and accelerated research.[Read More]]]> https://www.limsforum.com/115957-2/115957/feed/ 0 https://www.limsforum.com/115862-2/115862/?utm_source=rss&utm_medium=rss&utm_campaign=115862-2 https://www.limsforum.com/115862-2/115862/#respond Sun, 12 Apr 2026 04:10:09 +0000 https://www.limsforum.com/?p=115862 Kalleid will present at Certainty US 2026 on April 14-15 in Boston, MA. Principal Scientific Application Manager Jonathan Buttrick will discuss improving data quality after registration system migrations, sharing lessons from migrating multiple regional systems into one global Chemaxon Compound Registration deployment at Takeda Pharmaceuticals.[Read More]]]> https://www.limsforum.com/115862-2/115862/feed/ 0